1H NMR of A beta amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence.
暂无分享,去创建一个
J R Ghilardi | P W Mantyh | P. Mantyh | E. R. Stimson | M. Cummings | M. van Criekinge | J. Ghilardi | Y. Lu | M Cummings | E R Stimson | J P Lee | Y A Lu | A M Felix | W Llanos | A Behbin | M Van Criekinge | A. Felix | J. P. Lee | A. Behbin | W. Llanos | J. R. Ghilardi | Jonathan P. Lee | Ghilardi | Y.-a. Lu | Arthur M. Felix | William Llanos | M. VanCriekinge
[1] J. Reed,et al. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. , 1992, Journal of molecular biology.
[2] M. Karplus. Contact Electron‐Spin Coupling of Nuclear Magnetic Moments , 1959 .
[3] D. Selkoe,et al. Alzheimer's Disease: A Central Role for Amyloid , 1994, Journal of neuropathology and experimental neurology.
[4] P E Wright,et al. Folding of immunogenic peptide fragments of proteins in water solution. II. The nascent helix. , 1988, Journal of molecular biology.
[5] G Klopman,et al. Solution structure of residues 1-28 of the amyloid beta-peptide. , 1994, Biochemistry.
[6] Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[7] M J Ball,et al. beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Rance,et al. Suppression of cross-relaxation effects in TOCSY spectra via a modified DIPSI-2 mixing sequence , 1992 .
[9] J. Meienhofer,et al. Solid phase synthesis without repetitive acidolysis. Preparation of leucyl-alanyl-glycyl-valine using 9-fluorenylmethyloxycarbonylamino acids. , 2009, International journal of peptide and protein research.
[10] R G Griffin,et al. An unusual peptide conformation may precipitate amyloid formation in Alzheimer's disease: application of solid-state NMR to the determination of protein secondary structure. , 1991, Biochemistry.
[11] S. Estus,et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.
[12] S. Patt. Single- and multiple-frequency-shifted laminar pulses , 1992 .
[13] J. Reed,et al. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .
[14] P. Lansbury,et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.
[15] J. Ghiso,et al. In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease β-protein , 1986 .
[16] K. Beyreuther,et al. Amyloidogenicity of rodent and human βA4 sequences , 1993 .
[17] D. Selkoe,et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.
[18] M. Mullan,et al. Genetics and molecular advances in Alzheimer's disease , 1993, Trends in Neurosciences.
[19] H. Vinters,et al. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[20] G. Glenner,et al. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .
[21] P. Fraser,et al. pH-dependent structural transitions of Alzheimer amyloid peptides. , 1991, Biophysical journal.
[22] C. Barrow,et al. NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment. , 1992, Biochemistry.
[23] C. Cotman,et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.
[24] C. Barrow,et al. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. , 1992, Journal of molecular biology.
[25] S. Smallcombe. Solvent suppression with symmetrically-shifted pulses , 1993 .
[26] L. Pauling,et al. Configurations of Polypeptide Chains With Favored Orientations Around Single Bonds: Two New Pleated Sheets. , 1951, Proceedings of the National Academy of Sciences of the United States of America.
[27] C. Barrow,et al. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.
[28] D. Selkoe. The molecular pathology of Alzheimer's disease , 1991, Neuron.
[29] Ad Bax,et al. Rapid recording of 2D NMR spectra without phase cycling. Application to the study of hydrogen exchange in proteins , 1989 .
[30] H. Too,et al. Radioimmunoassay of Tachykinins , 1991 .
[31] F. Richards,et al. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. , 1992, Biochemistry.